Moreover, downregulation of KCTD12 promotes breast cancer cell proliferation and in vitro tumorigenesis, which implicates that KCTD12 may be served as a suppressive protein in the progression of breast cancer. This evidence concerns the gene KCTD12 and breast carcinoma.